Pancreatic Cell News Volume 15.03 | Jan 30 2024

    0
    9







    2024-01-30 | PACN 15.03


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 15.03 – 30 January, 2024
    TOP STORY

    Prospective Observational Study on Biomarkers of Response in Pancreatic Ductal Adenocarcinoma

    In this prospective observational study, 1,171 patients with PDAC who underwent pancreatectomy were enrolled and extensively followed-up. Proteomic profiling of 191 patient samples unveiled clinically relevant functional protein modules.
    [Nature Medicine]

    Full Article
    On-demand Webinar on Studying Cystic Fibrosis using Primary Human Nasal Epithelial Cells - Watch Now
    PUBLICATIONSRanked by the impact factor of the journal

    DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets

    Researchers demonstrated the use of cell type-specific DNA methylation markers for determining the fraction of specific cell types in human islet and pancreas specimens.
    [Diabetes]

    Abstract

    Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People with T2D (SURPASS-2)

    Investigators explored changes in biomarkers of beta-cell function and insulin sensitivity and efficacy profiles in baseline biomarker quartile analyses with tirzepatide compared to semaglutide.
    [Journal Of Clinical Endocrinology & Metabolism]

    Full Article

    Loss of the Golgi-Localized V-ATPase Subunit Does Not Alter Insulin Granule Formation or Pancreatic Islet β-Cell Function

    Researchers examined pH regulation of the Golgi and identified a partial alkalinization of the Golgi lumen in a diabetes model. They generated a β-cell-specific knockout of the v0a2 subunit of the v-ATPase pump, which anchors the v-ATPase to the Golgi membrane.
    [American Journal Of Physiology-Endocrinology And Metabolism]

    Abstract

    Differential Effects of OATP2B1 on Statin Accumulation and Toxicity in a Beta Cell Model

    Since OATP2B1 is present in beta cells of the human pancreas, scientists investigated if OATP2B1 facilitated the local accumulation of statins in a rat beta-cell model INS-1 832/13 thereby amplifying statin-induced toxicity.
    [Toxicology Mechanisms And Methods]

    Abstract

    Inhibition of ADAM9 Promotes the Selective Degradation of KRAS and Sensitizes Pancreatic Cancers to Chemotherapy

    Investigators identified a disintegrin and metalloproteinase domain (ADAM) 9 as a modulator of PDAC progression via stabilization of wild-type and mutant KRAS proteins.
    [Nature Cancer]

    Abstract

    Carfilzomib Relieves Pancreatitis-Initiated Pancreatic Ductal Adenocarcinoma by Inhibiting High-Temperature Requirement Protein A1

    Researchers clarified the expression of high-temperature requirement protein A1 (HTRA1) in PDAC using bioinformatics and immunohistochemistry of tissue chip, and found that HTRA1 was significantly upregulated in PDAC.
    [Cell Death Discovery]

    Full Article

    Identification and Validation of Stemness-Based and Ferroptosis-Related Molecular Clusters in Pancreatic Ductal Adenocarcinoma

    Investigators developed a stemness-based and ferroptosis-related prognostic model, which could help predict overall survival for PDAC patients. Targeting ferroptosis may be a promising therapeutic strategy to inhibit PDAC progression by suppressing cancer stem cells.
    [Translational Oncology]

    Full Article

    Myofibroblastic Cancer-Associated Fibroblast Subtype Heterogeneity in Pancreatic Cancer

    Scientists evaluated the gene and protein expression differences in two myofibroblastic cancer-associated fibroblast (CAF) lines using single-cell and bulk RNA-sequencing. They utilized proliferation and migration assays to determine the effect of different CAF lines on a tumor cell line.
    [Journal Of Surgical Oncology]

    Abstract
    View tips on how to share lab duties effectively.
    REVIEWS

    Deciphering Cellular Plasticity in Pancreatic Cancer for Effective Treatments

    The authors discuss the mechanisms of cellular plasticity involving cellular adaptation and tumor microenvironment and provided a comprehensive understanding of its role in therapy resistance and ways to overcome it.
    [Cancer And Metastasis Reviews]

    Abstract

    Current Status of Stem Cell Therapy for Type 1 Diabetes: A Critique and a Prospective Consideration

    Scientists identify the limitations that have to be overcome before stem cell therapy for diabetes becomes reliable and reproducible. As an alternative to cell therapy, the use of stem cell-derived extracellular vesicles is discussed as a future possibility.
    [Stem Cell Research & Therapy]

    Full Article
    INDUSTRY AND POLICY NEWS

    FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase II/III Adaptive Platform Trial for Metastatic Pancreatic Cancer

    FibroGen, Inc. announced the graduation and completion of the pamrevlumab experimental arm in the Pancreatic Cancer Action Network’s Precision PromiseSM Phase II/III adaptive platform trial, which evaluated pamrevlumab in combination with the chemotherapy treatments gemcitabine and nab-paclitaxel for patients with mPDAC.
    [FibroGen, Inc.]

    Press Release
    FEATURED EVENT

    2024 ACS Cancer Conference

    February 22 – 24, 2024
    Austin, Texas, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant- Type 2 Diabetes Mellitus-Induced Osteopathy

    University of Galway – Galway, Ireland, United Kingdom

    Assistant Professor – Surgical Oncology, Pancreatic

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    Associate Research Scientist – Digestive Organoids

    Columbia University Irving Medical Center – New York, New York, United States

    Open Rank Scientist – Throughput Cell-Based Assay

    Novo Nordisk – Beijing, China

    Postdoctoral Position – Liver and Gastrointestinal Diseases

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter